Figures computed from official regulatory filings — .
Statistical track record
Free accountWin rates, median returns and the proven-insider analysis come with a free account.
This page republishes public regulatory disclosures.
| Company | Type | Value · USD | Signals | Details | |
|---|---|---|---|---|---|
Urovant Sciences Ltd.Listing unverified | Buy | $56.7K | conv 23Cluster | SEC | |
Urovant Sciences Ltd.Listing unverified | Buy | $52.5K | conv 23Cluster | SEC | |
Urovant Sciences Ltd.Listing unverified | Buy | $56.9K | conv 29ClusterUnusual size | SEC | |
Sio Gene Therapies Inc.Listing unverified | Buy | $25M | conv 41Cluster | SEC | |
Myovant Sciences Ltd.Listing unverified | Buy | $22.5M | conv 39Cluster | SEC | |
Arbutus Biopharma CorpListing on record | BuyD (derivative) | $50M | ClusterFirst in 12mo | SEC |